AGEN · Agenus Inc. Common Stock
View on chartInsiders & Stakes
| Garo H. Armen Chairman and CEO | ▲ Buy | Grant | 371,108 Shares held | 7/10/2026 | View profile |
| Ulf Wiinberg Director | ▲ Buy | Open Market | 124,063 Shares held | 11/15/2023 | View profile |
| Susan B. Hirsch Director | ▲ Buy | Grant | 108,725 Shares held | 1/3/2023 | View profile |
| O'Day Steven J Chief Medical Officer | ▲ Buy | Grant | 57,116 Shares held | 6/18/2025 | View profile |
| Thomas L. Harrison Director | ▲ Buy | Grant | 51,988 Shares held | 10/1/2026 | View profile |
| KLASKIN CHRISTINE M PFO & PAO | ▲ Buy | Grant | 23,478 Shares held | 6/18/2025 | View profile |
| Jennifer Buell Chief Executive Officer | ▲ Buy | Grant | 19,738 Shares held | 5/2/2025 | View profile |
Transaction History
| Thomas L. Harrison | ▲ Buy | Grant | 4,443 | $31K | 10/1/2026 |
| Garo H. Armen | ▲ Buy | Grant | 4,852 | $16K | 7/10/2026 |
| Thomas L. Harrison | ▲ Buy | Grant | 8,547 | $31K | 7/1/2026 |
| Garo H. Armen | ▲ Buy | Grant | 5,364 | $16K | 6/26/2026 |
| Garo H. Armen | ▲ Buy | Grant | 4,925 | $16K | 6/12/2026 |
| Garo H. Armen | ▲ Buy | Grant | 4,644 | $16K | 5/29/2026 |
| Garo H. Armen | ▲ Buy | Grant | 4,540 | $16K | 5/15/2026 |
| Garo H. Armen | ▲ Buy | Grant | 4,233 | $16K | 5/1/2026 |
| Garo H. Armen | ▲ Buy | Grant | 3,403 | $16K | 4/17/2026 |
| Garo H. Armen | ▲ Buy | Grant | 4,629 | $15K | 4/3/2026 |
| Thomas L. Harrison | ▲ Buy | Grant | 9,228 | $31K | 4/1/2026 |
| Garo H. Armen | ▲ Buy | Grant | 3,983 | $15K | 3/20/2026 |
| Garo H. Armen | ▲ Buy | Grant | 4,994 | $15K | 3/6/2026 |
| Garo H. Armen | ▲ Buy | Grant | 4,829 | $15K | 2/20/2026 |
| Garo H. Armen | ▲ Buy | Grant | 5,027 | $15K | 2/6/2026 |
| Garo H. Armen | ▲ Buy | Grant | 4,562 | $15K | 1/23/2026 |
| Garo H. Armen | ▲ Buy | Grant | 3,780 | $15K | 1/9/2026 |
| Thomas L. Harrison | ▲ Buy | Grant | 7,691 | $31K | 1/2/2026 |
| Garo H. Armen | ▲ Buy | Grant | 4,942 | $16K | 12/26/2025 |
| Garo H. Armen | ▲ Buy | Grant | 4,316 | $16K | 12/12/2025 |
| Garo H. Armen | ▲ Buy | Grant | 3,587 | $16K | 11/28/2025 |
| Garo H. Armen | ▲ Buy | Grant | 3,769 | $16K | 11/14/2025 |
| Garo H. Armen | ▲ Buy | Grant | 4,120 | $16K | 10/31/2025 |
| Garo H. Armen | ▲ Buy | Grant | 4,216 | $16K | 10/17/2025 |
| Garo H. Armen | ▲ Buy | Grant | 3,951 | $16K | 10/3/2025 |
| Thomas L. Harrison | ▲ Buy | Grant | 5,780 | $29K | 10/1/2025 |
| Garo H. Armen | ▲ Buy | Grant | 3,734 | $16K | 9/19/2025 |
| Garo H. Armen | ▲ Buy | Grant | 3,778 | $16K | 9/5/2025 |
| Garo H. Armen | ▲ Buy | Grant | 3,619 | $16K | 8/22/2025 |
| Garo H. Armen | ▲ Buy | Grant | 3,407 | $16K | 8/8/2025 |
| Garo H. Armen | ▲ Buy | Grant | 2,745 | $16K | 7/25/2025 |
| Garo H. Armen | ▲ Buy | Grant | 2,317 | $16K | 7/11/2025 |
| Thomas L. Harrison | ▲ Buy | Grant | 7,401 | $26K | 7/1/2025 |
| Garo H. Armen | ▲ Buy | Grant | 3,436 | $16K | 6/27/2025 |
| O'Day Steven J | ▲ Buy | Grant | 43,497 | $194K | 6/18/2025 |
| KLASKIN CHRISTINE M | ▲ Buy | Grant | 15,782 | $71K | 6/18/2025 |
| Garo H. Armen | ▲ Buy | Grant | 61,397 | $274K | 6/18/2025 |
| Garo H. Armen | ▲ Buy | Grant | 3,480 | $16K | 6/13/2025 |
| Garo H. Armen | ▲ Buy | Grant | 4,769 | $16K | 5/30/2025 |
| Garo H. Armen | ▲ Buy | Grant | 4,700 | $16K | 5/16/2025 |
| Garo H. Armen | ▲ Buy | Grant | 5,260 | $16K | 5/2/2025 |
| Jennifer Buell | ▲ Buy | Grant | 581 | $2K | 5/2/2025 |
| Jennifer Buell | ▲ Buy | Grant | 869 | $2K | 4/18/2025 |
| Garo H. Armen | ▲ Buy | Grant | 7,886 | $16K | 4/18/2025 |
| Jennifer Buell | ▲ Buy | Grant | 1,159 | $2K | 4/4/2025 |
| Garo H. Armen | ▲ Buy | Grant | 10,288 | $16K | 4/4/2025 |
| Thomas L. Harrison | ▲ Buy | Grant | 8,898 | $26K | 4/1/2025 |
| Jennifer Buell | ▲ Buy | Grant | 1,123 | $2K | 3/21/2025 |
| Garo H. Armen | ▲ Buy | Grant | 9,243 | $15K | 3/21/2025 |
| Jennifer Buell | ▲ Buy | Grant | 409 | $961 | 3/7/2025 |
| Garo H. Armen | ▲ Buy | Grant | 6,332 | $15K | 3/7/2025 |
| Jennifer Buell | ▲ Buy | Grant | 626 | $2K | 2/21/2025 |
| Garo H. Armen | ▲ Buy | Grant | 4,483 | $15K | 2/21/2025 |
| Jennifer Buell | ▲ Buy | Grant | 545 | $2K | 2/21/2025 |
| Jennifer Buell | ▲ Buy | Grant | 516 | $2K | 2/7/2025 |
| Garo H. Armen | ▲ Buy | Grant | 4,251 | $15K | 2/7/2025 |
| Jennifer Buell | ▼ Sell | Tax Withholding | 270 | $964 | 1/24/2025 |
| Garo H. Armen | ▲ Buy | Grant | 4,169 | $15K | 1/24/2025 |
| Jennifer Buell | ▲ Buy | Grant | 776 | $3K | 1/24/2025 |
| Garo H. Armen | ▲ Buy | Grant | 4,777 | $15K | 1/10/2025 |
| Garo H. Armen | ▲ Buy | Grant | 5,931 | $16K | 12/27/2024 |
| Garo H. Armen | ▲ Buy | Grant | 5,347 | $16K | 12/13/2024 |
| Garo H. Armen | ▲ Buy | Grant | 4,769 | $16K | 11/29/2024 |
| Garo H. Armen | ▲ Buy | Grant | 5,997 | $16K | 11/15/2024 |
| Garo H. Armen | ▲ Buy | Grant | 4,207 | $17K | 11/1/2024 |
| Garo H. Armen | ▲ Buy | Grant | 3,530 | $16K | 10/18/2024 |
| Garo H. Armen | ▲ Buy | Grant | 3,349 | $16K | 10/4/2024 |
| Garo H. Armen | ▲ Buy | Grant | 2,793 | $16K | 9/20/2024 |
| Garo H. Armen | ▲ Buy | Grant | 3,295 | $16K | 9/6/2024 |
| Garo H. Armen | ▲ Buy | Grant | 2,982 | $16K | 8/23/2024 |
| Garo H. Armen | ▲ Buy | Grant | 3,204 | $16K | 8/9/2024 |
| Garo H. Armen | ▲ Buy | Grant | 2,486 | $16K | 7/26/2024 |
| Garo H. Armen | ▲ Buy | Grant | 1,046 | $16K | 7/12/2024 |
| Garo H. Armen | ▲ Buy | Grant | 973 | $16K | 6/28/2024 |
| Garo H. Armen | ▲ Buy | Grant | 1,055 | $16K | 6/14/2024 |
| Garo H. Armen | ▲ Buy | Grant | 1,040 | $16K | 5/31/2024 |
| Garo H. Armen | ▲ Buy | Grant | 1,502 | $16K | 5/17/2024 |
| Garo H. Armen | ▲ Buy | Grant | 1,248 | $16K | 5/3/2024 |
| Garo H. Armen | ▲ Buy | Grant | 3,080 | $16K | 4/19/2024 |
| Garo H. Armen | ▲ Buy | Grant | 32,697 | $16K | 4/5/2024 |
| Garo H. Armen | ▲ Buy | Grant | 27,163 | $15K | 3/22/2024 |
| Garo H. Armen | ▲ Buy | Grant | 22,136 | $15K | 3/8/2024 |
| Garo H. Armen | ▲ Buy | Grant | 21,815 | $15K | 2/23/2024 |
| Garo H. Armen | ▲ Buy | Open Market | 500,000 | $324K | 2/15/2024 |
| Garo H. Armen | ▲ Buy | Grant | 19,778 | $15K | 2/9/2024 |
| Garo H. Armen | ▲ Buy | Grant | 22,475 | $15K | 1/26/2024 |
| Garo H. Armen | ▲ Buy | Grant | 23,177 | $15K | 1/12/2024 |
| Garo H. Armen | ▲ Buy | Grant | 23,453 | $19K | 12/29/2023 |
| Garo H. Armen | ▲ Buy | Grant | 23,453 | $16K | 12/15/2023 |
| Garo H. Armen | ▲ Buy | Grant | 20,727 | $16K | 12/1/2023 |
| Garo H. Armen | ▲ Buy | Grant | 23,511 | $16K | 11/17/2023 |
| Ulf Wiinberg | ▲ Buy | Open Market | 25,000 | $19K | 11/15/2023 |
| Garo H. Armen | ▲ Buy | Grant | 19,200 | $16K | 11/3/2023 |
| Garo H. Armen | ▲ Buy | Grant | 18,142 | $16K | 10/20/2023 |
| Garo H. Armen | ▲ Buy | Grant | 15,305 | $16K | 10/6/2023 |
| Garo H. Armen | ▲ Buy | Grant | 13,888 | $16K | 9/22/2023 |
| Garo H. Armen | ▲ Buy | Grant | 13,145 | $16K | 9/8/2023 |
| KLASKIN CHRISTINE M | ▲ Buy | Grant | 31,294 | $77K | 1/5/2023 |
| Garo H. Armen | ▲ Buy | Grant | 241,383 | $591K | 1/5/2023 |
| O'Day Steven J | ▲ Buy | Grant | 109,381 | $268K | 1/5/2023 |
| Susan B. Hirsch | ▲ Buy | Grant | 7,239 | $19K | 1/3/2023 |
| Susan B. Hirsch | ▲ Buy | Grant | 7,216 | $19K | 10/3/2022 |
| Susan B. Hirsch | ▲ Buy | Grant | 10,138 | $19K | 7/1/2022 |
| Susan B. Hirsch | ▲ Buy | Grant | 6,811 | $19K | 4/1/2022 |
| KLASKIN CHRISTINE M | ▲ Buy | Grant | 29,587 | $74K | 2/2/2022 |
| Garo H. Armen | ▲ Buy | Grant | 237,011 | $595K | 2/2/2022 |
| O'Day Steven J | ▲ Buy | Grant | 101,682 | $255K | 2/2/2022 |
| O'Day Steven J | ▼ Sell | Open Market | 38,679 | $118K | 1/6/2022 |
| O'Day Steven J | ▲ Buy | Option Exercise | 100,000 | — | 1/4/2022 |
| Susan B. Hirsch | ▲ Buy | Grant | 4,677 | $19K | 1/3/2022 |
| Susan B. Hirsch | ▲ Buy | Grant | 3,257 | $19K | 10/1/2021 |
| Garo H. Armen | ▲ Buy | Option Exercise | 119,178 | $400K | 9/13/2021 |
| Garo H. Armen | ▼ Sell | Open Market | 82,107 | $534K | 9/13/2021 |
| KLASKIN CHRISTINE M | ▼ Sell | Open Market | 11,120 | $72K | 9/10/2021 |
| KLASKIN CHRISTINE M | ▲ Buy | Option Exercise | 16,563 | $56K | 9/10/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Agenus Fair Value Adjusted Following Trial Updates and Financing
Agenus saw its estimated fair value rise after recent trial updates and new financing activities. These developments provide context for the stock's current position within its 52-week range. The news highlights ongoing corporate actions that may influence how analysts view the company's future prospects.
Agenus Fair Value Adjusted Following Trial Updates and Financing. Agenus saw its estimated fair value rise after recent trial updates and new financing activities. These developments provide context for the stock's current position within its 52-week range. The news highlights ongoing corporate actions that may influence how analysts view the company's future prospects.